DAX6.706-1,2%  Dow12.777-0,9%  Euro1,3181-0,8% 
ESt502.487-1,4%  Nas2.907-0,7%  Öl117,5-1,0% 
TDax770,9-0,3%  Nikkei8.947-0,6%  Gold1.720-0,6% 
Home > Aktien > Covalent Aktie > Nachrichten zu Covalent

Covalent Aktie [WKN: 898635 / ISIN: US2228151021]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
Börsenplätze Kursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
 Realtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Covalent. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Covalent

14.08.08Encorium Reports 2008 Second Quarter Financial Results
14.08.08Encorium Group Schedules Second Quarter Financial Results and Conference Call
13.08.08Encorium Group Signs $3.5 Million of New Contracts for Vaccines Clinical Trials
22.07.08Encorium Group Signs Additional New Contracts Valued at $5.0 Million
17.07.08Encorium Group Announces $5.1 Million New Business Contract For A Multinational Cardiovascular Trial Of An Innovative Anti-thrombotic Agent
11.06.08Encorium Group, Inc. Announces Signing of Letter of Intent to Acquire Prologue Research International, Inc.
11.06.08Encorium Group, Inc. Announces Signing of Letter of Intent to Combine with Linkcon; Expected Expansion Will Create Global CRO
22.05.08Encorium Group, Inc. Announces $3.2 Million of New Business Contracts for Europe and North America
15.05.08Encorium Reports 2008 First Quarter Financial Results
13.05.08Encorium Group Appoints Philip L. Calamia Interim Chief Financial Officer
12.05.08Encorium Group Schedules First Quarter Financial Results and Conference Call
18.04.08Encorium Group, Inc. Announces the Resignation of Lawrence R. Hoffman as Chief Financial Officer; Company to Immediately Begin Search for Successor
07.04.08Encorium Group, Inc. Announces Additional $2.2 Million of New Business Contracts With Multiple European and U.S. Biopharmaceutical Companies
31.03.08Encorium Group, Inc. Announces $1.6 Million Contract for a Phase 2 Trial of an Innovative Immunotherapeutic Vaccine for the Treatment of Hypertension
25.03.08Encorium Reports 2007 Fourth Quarter and Full Year Financial Results
24.03.08Encorium Group, Inc. Announces $2.5 Million of Awarded New Business Contracts With Multiple European and U.S. Biopharmaceutical Companies
20.03.08Encorium Group Schedules Fourth Quarter Financial Results and Conference Call
21.02.08Encorium Group, Inc. Announces Realignment of Its Senior Management Team to Meet Its Global Growth Objectives
18.01.08Encorium Group, Inc. Announces $3.4 Million of Awarded New Business Contracts
10.01.08Encorium Group, Inc. Announces Signing of $1.7 Million in Contracts with Leading International Biotechnology Company for Clinical Trials in Oncology and Rheumatology
07.01.08Encorium Group, Inc. Announces the Signing of a $2.0 Million Contract for Data Management Services for a Global Pharmaceutical Company
12.11.07Encorium Reports 2007 Third Quarter Financial Results
12.11.07Encorium Group Appoints Biopharmaceutical Industry Veteran Linda Nardone Ph.D. as Chief Operating Officer
05.11.07Encorium Group Schedules Third Quarter Financial Results and Conference Call
25.10.07Encorium Group, Inc. Announces $4 Million of Awarded New Business Contracts
28.08.07Encorium Group Forms Joint Venture in Biostatistics, Data Management, and Consulting Services
13.08.07Encorium Reports 2007 Second Quarter Financial Results
06.08.07Encorium Group Schedules Second Quarter Financial Results and Conference Call
26.07.07Encorium Group, Inc. Schedules Date for Annual Meeting of Stockholders
17.07.07Encorium Group, Inc. Announces $4.0 Million of Additional New Business Contracts
12.07.07Encorium Group, Inc. Announces $1.7 Million Contract With Japanese Biotechnology Company For Phase 2 Clinical Trial For Major Depressive Disorder
10.07.07Encorium Group, Inc. Announces $3.0 Million in New Contracts for Clinical Trials in Women's Health
21.06.07Encorium Group, Inc. Announces $3.8 Million Contract For Phase 2 Clinical Trial in Herpes Zoster (Shingles)
19.06.07Oramed Pharmaceuticals Signs Agreement With Encorium Group To Commence Investigational New Drug Application
01.11.06Encorium Group Completes Combination with Remedium

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon